Drugs / Vitamine C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02109315 | May 2014 → May 2015 | type 1 diabetes mellitus | Anna Cruceta | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05901337 Background | Mar → Jun 2022 | — | Cairo University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamine C | “Vitamine C: The recommended dietary dose 200 mg/day vitamin c” NCT05901337 ↗ |
| Route | Intravenous | “C Vitamine endovenous 1000 mg/5 ml. Infusion dose: 30 mgr/min” NCT02109315 ↗ |